首页> 外国专利> Method of obtaining recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media

Method of obtaining recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media

机译:获得适合在无血清和无蛋白质培养基中生长的重组哺乳动物骨髓瘤细胞系的方法

摘要

The present invention relates to a method of recovering mammalian cell clones adapted to serum and protein-free media, the procedure includes a two-stage adaptation process to grow in that condition. The present invention discloses a critical protein concentration interval in which cells must grow in order to gain the capacity to survive in serum and protein-free condition, once the cells have grown at the critical interval concentrations, subsequent decreases of the concentration will affect neither viability nor cellular doubling time. The critical protein concentration interval is cell line specific. ??Furthermore, in the present invention mammalian cells clones are disclosed, which are stable in serum- and protein-free media for at least 40 generations; additionally, clones disclosed in the present invention express a recombinant product. ??The cell clones disclosed in the present invention produce the humanized anti-EGF-R antibody hR3, the humanized anti-CD6 antibody T1hT, the chimeric anti CD3 antibody T3Q, or fragments thereof.
机译:本发明涉及一种回收适于无血清和无蛋白培养基的哺乳动物细胞克隆的方法,该方法包括在该条件下生长的两阶段适应过程。本发明公开了临界蛋白质浓度间隔,其中细胞必须生长以便获得在无血清和无蛋白质条件下存活的能力,一旦细胞以临界间隔浓度生长,随后浓度的降低将不会影响生存力。也不是细胞倍增时间。临界蛋白质浓度间隔是细胞系特异性的。此外,在本发明中,公开了哺乳动物细胞克隆,它们在无血清和无蛋白质的培养基中稳定至少40代。另外,本发明中公开的克隆表达重组产物。本发明公开的细胞克隆产生人源化抗EGF-R抗体hR3,人源化抗CD6抗体T1hT,嵌合抗CD3抗体T3Q或其片段。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号